Developing advanced imaging techniques to understand and treat Alzheimer's disease.
Center for Advanced Metabolic Imaging in Precision Medicine (CAMIPM)
This study is working on new imaging tools to help doctors see how Alzheimer's affects the brain and to track how well treatments are working, all with the goal of improving care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11123506 on NIH RePORTER |
What this research studies
The Center for Advanced Metabolic Imaging in Precision Medicine (CAMIPM) focuses on creating innovative noninvasive imaging technologies to better understand metabolic processes in diseases like Alzheimer's. This research aims to develop and implement advanced imaging biomarkers that can help identify disease mechanisms and monitor treatment responses. By collaborating with clinical research institutes, the project will translate these technologies from laboratory settings to real-world clinical applications, enhancing patient care. The research includes various imaging techniques to assess metabolism in the brain and other tissues, providing insights into Alzheimer's disease progression.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those at risk for developing it.
Not a fit: Patients with conditions unrelated to Alzheimer's disease or those who do not have any cognitive impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment monitoring for patients with Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for understanding neurodegenerative diseases, indicating potential success for this approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Reddy, Ravinder — University of Pennsylvania
- Study coordinator: Reddy, Ravinder
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.